• AI KATANA
  • Posts
  • How AI and other emerging tech showed up during the FIFA Women's World Cup

How AI and other emerging tech showed up during the FIFA Women's World Cup

Also: Parkinson's disease could be detected early with AI scans, scientists say

Author

AI KATANA
August 22, 2023

Welcome!

During the recent FIFA Women's World Cup, the influence of AI and emerging tech was prominently displayed with innovations ranging from Orange's AI-driven ad tackling sexism to Cadbury's AI-enabled personalized posters. In medical advancements, AI eye scans have shown promise in early Parkinson's disease detection, potentially identifying the ailment up to seven years before clinical symptoms. Nvidia solidifies its leadership in the AI chip market, capitalizing on a decade of strategic moves, now commanding over 70% of AI chip sales. However, a US court has ruled that AI-generated art lacks copyright protection, emphasizing human creation in intellectual property. In the app realm, BeFake AI now allows users to artistically modify photos, counteracting the prevailing push for authentic content. Lastly, Genesis Therapeutics has garnered $200M for its unique AI-driven drug discovery platform, set to revolutionize treatments for challenging diseases.

Sliced:

  • ⚽️ How AI and other emerging tech showed up during the FIFA Women's World Cup

  • 🧑🏻‍⚕️ Parkinson's disease could be detected early with AI scans, scientists say

  • 🦾 How Nvidia Built a Competitive Moat Around A.I. Chips

  • © AI-generated art cannot receive copyrights, US court says

During the FIFA Women's World Cup, the integration of AI and emerging technology was evident in various facets of the event. Companies utilized this global platform to experiment with innovative tools, leading to memorable campaigns and engagements. A prime example was Orange's advertisement, which utilized AI-generated deepfakes to address sexism in soccer. Cadbury, on the other hand, allowed fans to generate personalized posters with AI. Additionally, Futureverse collaborated with FIFA to design a mobile game where participants could create and pit AI-generated soccer players against one another. FIFA also utilized AI for content moderation, blocking abusive posts on social media platforms. Furthermore, Snapchat leveraged augmented reality features to engage fans, including AR lenses and real-time data integrations, providing an immersive "second-screen experience". Meanwhile, blockchain-based gaming companies such as Matchday also made their presence known, allowing fans to engage with quiz questions and win player cards. As emerging technologies gain traction, their role in global sporting events like the World Cup is set to become increasingly significant.

AI-powered eye scans could offer early detection of Parkinson's disease even before symptoms manifest, according to a study by teams from London's Moorfields Eye Hospital and the UCL Institute of Ophthalmology. By analyzing data from optical coherence tomography (OCT) scans of over 154,830 patients, the AI identified retinal markers, notably a thinner ganglion cell-inner plexiform layer and inner nuclear layer, in individuals with Parkinson's an average of seven years prior to clinical presentation. Given that OCT scans are already a non-invasive, cost-effective, and quick method used by opticians, experts believe this technique could revolutionize early detection of Parkinson's, with potential applications for other neurodegenerative diseases like Alzheimer's and multiple sclerosis.

Nvidia, the global leader in A.I. chips, has constructed a robust competitive advantage in the A.I. market over the past decade. Recognizing the potential of A.I. early on, the company strategically tailored its graphics processing units (GPUs) for A.I.-related tasks and invested heavily in software development to support these tasks. This multifaceted approach transformed Nvidia from merely a component supplier to an integral part of the A.I. ecosystem, collaborating with top scientists and startups, and providing a comprehensive suite of services for A.I. development. Beyond the hardware, Nvidia has fostered a vast community of A.I. developers loyal to its platform, ensuring consistent innovation using its products. As a testament to its dominance, despite the emergence of other tech giants in the A.I. chip market, Nvidia accounts for over 70% of A.I. chip sales and remains a key player in training generative A.I. models.

A US court in Washington, DC, has ruled that art generated by artificial intelligence without human intervention cannot be copyrighted under US law. The decision came after computer scientist Stephen Thaler filed an application for his AI system, DABUS, which the Copyright Office rejected, stating that only works with human authors can be copyrighted. The same stance was taken by US District Judge Beryl Howell. Previously, Thaler's attempts to obtain US patents for inventions he claimed were created by DABUS met with similar results. While Thaler plans to appeal, the ruling underscores the evolving complexities of intellectual property in the age of generative AI, with the Copyright Office emphasizing the importance of human authorship in copyright claims.

🛠️ AI tools updates

BeFake AI, the latest social media application, offers users the ability to utilize AI in transforming their photographs into artistic creations for sharing. This new platform playfully challenges the authenticity movement in social media, notably parodying BeReal, an app that promotes genuine, unfiltered photo sharing. With BeFake, users are prompted randomly to upload photos that are then modified using AI tools, resembling functionalities from AI art generators like DALL-E. While the edited images are posted, viewers can also swipe to compare them with the originals. For those who prefer a layer of privacy, the app offers a subscription model that provides features like concealing the original image. However, users should be cautious as the app's terms permit the use of personal data for various purposes, including refining their AI models.

💵 Venture Capital updates

Genesis Therapeutics, a Burlingame, California-based AI-powered drug discovery startup, has secured $200 million in a Series B funding round, raising its total funding to over $280 million. The financing round, co-led by Andreessen Horowitz and an undisclosed U.S. life-sciences-focused investor, also saw participation from BlackRock, NVentures, Menlo Ventures, and others. Originating as a Stanford University spinout in 2019, Genesis is crafting the AI platform, GEMS, aimed at generating small-molecule drug compounds for challenging diseases, with a current focus on oncology. Differentiating itself with a physics-centric AI platform, Genesis merges physics-based computational chemistry methods with machine learning, providing a unique approach to drug discovery. This approach has led to partnerships with pharma giants like Genentech and Eli Lilly. The new funds will be channeled towards the company's clinical testing phase and expanding its AI platform to explore new therapeutic targets.

🫡 Meme of the day

⭐️ Generative AI image of the day

,